A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)

Condition:   Major Depressive Disorder Interventions:   Drug: REL-1017;   Drug: Placebo Sponsor:   Relmada Therapeutics, Inc. Recruiting

Source: ClinicalTrials.gov - October 18, 2021 Category: Research Source Type: clinical trials